ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

PEPG PepGen Inc

14.49
0.59 (4.24%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
PepGen Inc PEPG 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.59 4.24% 14.49 05:00:49
개장가 저가 고가 종가 전일 종가
14.00 13.41 14.59 14.49 13.90
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
14/03/202405:05GLOBEPepGen to Participate in Upcoming Investor Conferences
13/03/202420:00GLOBEPepGen Receives U.S. FDA Orphan Drug and Rare Pediatric..
07/03/202406:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/03/202406:01GLOBEPepGen Reports Fourth Quarter and Full Year 2023 Financial..
07/03/202406:00EDGAR2Form 8-K - Current report
04/03/202421:27EDGAR2Form 8-K - Current report
04/03/202421:00GLOBEPepGen Announces Clearance of CTA by UK Medicines &..
02/03/202407:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/02/202422:00EDGAR2Form 8-K - Current report
20/02/202422:00GLOBEPepGen Receives U.S. FDA Fast Track Designation for..
08/02/202406:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/02/202421:36EDGAR2Form 8-K - Current report
07/02/202421:30GLOBEPepGen Announces Pricing of $80.1 Million Underwritten..
17/01/202422:00EDGAR2Form 8-K - Current report
17/01/202421:00GLOBEMary Beth DeLena Joins PepGen as General Counsel and..
08/01/202421:00EDGAR2Form 8-K - Current report
08/01/202421:00GLOBEPepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase..
18/12/202322:00EDGAR2Form 8-K - Current report
18/12/202322:00GLOBEPepGen Announces First Patient Dosed in Phase 1 FREEDOM-DM1..
15/11/202322:00EDGAR2Form 8-K - Current report
15/11/202322:00GLOBEPepGen Announces Appointment of Howard Mayer, M.D. to Board..
08/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:00EDGAR2Form 8-K - Current report
08/11/202322:00GLOBEPepGen Reports Third Quarter 2023 Financial Results and..
12/10/202320:52DJNFDA Lifts Hold on PepGen's New Drug Application for..
12/10/202320:05EDGAR2Form 8-K - Current report
12/10/202320:00GLOBEPepGen Inc. Announces FDA has Lifted the Clinical Hold on..
28/09/202305:16GLOBEPepGen Announces Upcoming Presentations at the 28th Annual..
07/09/202305:06EDGAR2Form 8-K - Current report
07/09/202305:05GLOBEPepGen Inc. Announces Clearance of CTA by Health Canada to..
06/09/202321:16EDGAR2Form 8-K - Current report
06/09/202321:00GLOBEPepGen Inc. Presents PGN-EDODM1 Preclinical Data Supporting..
01/09/202321:00GLOBEPepGen Announces Presentations at the 2023 Myotonic..
08/08/202321:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/08/202321:27EDGAR2Form 8-K - Current report
08/08/202321:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202321:15EDGAR2Form 8-K - Current report
08/08/202321:15GLOBEPepGen Reports Second Quarter 2023 Financial Results and..
14/06/202306:07DJNPepGen Withdraws Guidance on Launch of Study for Muscle..
14/06/202305:05GLOBEPepGen Inc. Provides Update on Planned Initiation of Phase 1..
31/05/202306:24DJNPepGen Shares Tumble 18.4% After FDA Issues Hold Notice on..
31/05/202305:05GLOBEPepGen Inc. Announces Clinical Hold in the U.S. on IND..
18/05/202320:00GLOBEPepGen Announces Clearance by Health Canada of CTA for..
11/05/202320:00GLOBEPepGen Reports First Quarter 2023 Financial Results and..
04/05/202321:00GLOBEPepGen to Participate in the Bank of America Securities 2023..

최근 히스토리

Delayed Upgrade Clock